EEM vs IBB
iShares MSCI Emerging Markets ETF vs iShares Biotechnology ETF
EEM—
iShares MSCI Emerging Markets ETF
Liquid emerging-market equities.
Expense: —Yield: —
IBB—
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: —Yield: —
Side-by-side metrics
| Metric | EEM | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | iShares | iShares |
EEM top holdings
Holdings data unavailable for EEM.
IBB top holdings
Holdings data unavailable for IBB.
About EEM
EEM (iShares MSCI Emerging Markets ETF) is Liquid emerging-market equities.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies.